Just as quickly, investors are losing their appetite for the trade. After a disappointing trial of a new Novo Nordisk drug ...
Overweight scores continue from 25-30. And over 30 is obese. Quetelet merely used this early calculation as a descriptor. He did not make any medical proclamations. The Quetelet Index became ...
A document endorsed by more than 56 experts worldwide, published in 'The Lancet Diabetes & Endocrinology', proposes a change ...
Body Mass Index, or BMI, has long been criticized as an unreliable method for measuring obesity — and now a group of experts ...
BMI has long been considered a flawed measure that can over-diagnose or underdiagnose obesity, which is currently defined as ...
An international commission made the case for focusing on body fat quantity and the illnesses people experience.
The writer has published ‘Magic Pill,’ a book where based on his own experience with weight-loss drugs he embarks on a ...
Weight-loss medicines such as Ozempic might raise a person’s likelihood of developing conditions including arthritis.
(THE CONVERSATION) Atrial fibrillation, or A-fib, is an irregular heart rhythm that increases a person’s risk of stroke, heart failure and even premature death. While many risk factors contribute to A ...
Novo Nordisk said a higher dose of its drug Wegovy led to greater weight loss in patients during a late-stage trial, but the ...
Using body-mass index to tell who is overweight or obese is not reliable and can result in misdiagnosis, the Commission on ...
As weight loss medications like Ozempic and Wegovy become increasingly popular, questions arise about whether the nation is approaching pea ...